Novo Nordisk, the Danish pharmaceutical giant, has entered a significant partnership with Vivtex, a biotech startup co-founded by renowned entrepreneur Robert Langer, to develop innovative oral formulations of its obesity
Novo Nordisk, the Danish pharmaceutical giant, has entered a significant partnership with Vivtex, a biotech startup co-founded by renowned entrepreneur Robert Langer, to develop innovative oral formulations of its obesity
Weight-loss drugs have experienced a remarkable rise in the UK since their approval in 2023. As many as 1.5 million Britons are now reported to be using GLP-1 medications for
Over a million people in the United Kingdom who use weight-loss jabs such as Mounjaro Ozempic and Wegovy may be risking their travel and health insurance due to confusion over
British supermarkets are experiencing their first decline in grocery sales volumes this year, with experts attributing part of this downturn to the rising popularity of weight-loss medications. Market research firm






